We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Kinnate Biopharma Inc (KNTE) USD0.0001

Sell:$2.58 Buy:$2.59 Change: $0.12 (4.86%)
NASDAQ:1.14%
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Sell:$2.58
Buy:$2.59
Change: $0.12 (4.86%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Sell:$2.58
Buy:$2.59
Change: $0.12 (4.86%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.


Recent deals

Date Name Position (if held) Deal type Number of
shares dealt
Price Value of trade Shares
remaining
01 Dec 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $2.25 $1,217.25 68,146.00
01 Dec 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $2.25 $3,282.75 65,593.00
01 Dec 2023 Meltz, Mark A COO Sell (tax related) 541.00 $2.25 $1,217.25 28,136.00
01 Dec 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $2.25 $1,217.25 68,146.00
01 Dec 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $2.25 $3,282.75 65,593.00
01 Dec 2023 Meltz, Mark A COO Sell (tax related) 541.00 $2.25 $1,217.25 28,136.00
01 Sep 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $2.35 $3,428.65 67,052.00
01 Sep 2023 Meltz, Mark A COO Sell (tax related) 541.00 $2.35 $1,271.35 28,677.00
01 Sep 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $2.35 $1,271.35 68,687.00
01 Dec 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $2.25 $1,217.25 68,146.00
01 Dec 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $2.25 $3,282.75 65,593.00
01 Dec 2023 Meltz, Mark A COO Sell (tax related) 541.00 $2.25 $1,217.25 28,136.00
01 Sep 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $2.35 $3,428.65 67,052.00
01 Sep 2023 Meltz, Mark A COO Sell (tax related) 541.00 $2.35 $1,271.35 28,677.00
01 Sep 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $2.35 $1,271.35 68,687.00
01 Jun 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541.00 $4.30 $2,326.30 69,228.00
01 Jun 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459.00 $4.30 $6,273.70 68,511.00
01 Jun 2023 Meltz, Mark A COO Sell (tax related) 541.00 $4.30 $2,326.30 29,218.00
08 May 2023 FORESITE CAPITAL MANAGEMENT IV, LLC N/A Regular purchase transaction 1,780,000.00 $2.80 $4,984,000.00 3,525,957.00
08 May 2023 Tananbaum, James B. (Jim) Director Regular purchase transaction 1,780,000.00 $2.80 $4,984,000.00 3,525,957.00
05 May 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 981,023.00 $2.82 $2,766,484.86 1,368,339.00
05 May 2023 Gordon, Carl L Director Regular purchase transaction 981,023.00 $2.82 $2,766,484.86 1,368,339.00
04 May 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 479,909.00 $2.75 $1,319,749.75 4,738,453.00
04 May 2023 Gordon, Carl L Director Regular purchase transaction 479,909.00 $2.75 $1,319,749.75 4,738,453.00
02 May 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 338,262.00 $2.67 $903,159.54 4,425,462.00
02 May 2023 Gordon, Carl L Director Regular purchase transaction 338,262.00 $2.67 $903,159.54 4,425,462.00
01 May 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 716,157.00 $2.62 $1,876,331.34 4,204,852.00
01 May 2023 Gordon, Carl L Director Regular purchase transaction 716,157.00 $2.62 $1,876,331.34 4,204,852.00
28 Apr 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 350,749.00 $2.55 $894,409.95 3,737,784.00
28 Apr 2023 Gordon, Carl L Director Regular purchase transaction 350,749.00 $2.55 $894,409.95 3,737,784.00

5 most significant trades

Date Name Position (if held) Deal type Number of
shares dealt
Price Value of trade Shares
remaining
01 Dec 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459 $2.25 $3,282.75 65,593.00
01 Dec 2023 Meltz, Mark A COO Sell (tax related) 541 $2.25 $1,217.25 28,136.00
01 Dec 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541 $2.25 $1,217.25 68,146.00
01 Sep 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459 $2.35 $3,428.65 67,052.00
01 Dec 2023 Krishnamohan, Neha CFO Sell (tax related) 1,459 $2.25 $3,282.75 65,593.00
01 Sep 2023 Williams, Richard Thomas Chief Level Officer Sell (tax related) 541 $2.35 $1,271.35 68,687.00
01 Sep 2023 Meltz, Mark A COO Sell (tax related) 541 $2.35 $1,271.35 28,677.00
01 Dec 2023 Meltz, Mark A COO Sell (tax related) 541 $2.25 $1,217.25 28,136.00
08 May 2023 Tananbaum, James B. (Jim) Director Regular purchase transaction 1,780,000 $2.80 $4,984,000.00 3,525,957.00
08 May 2023 FORESITE CAPITAL MANAGEMENT IV, LLC N/A Regular purchase transaction 1,780,000 $2.80 $4,984,000.00 3,525,957.00
05 May 2023 ORBIMED ADVISORS LLC N/A Regular purchase transaction 981,023 $2.82 $2,766,484.86 1,368,339.00
05 May 2023 Gordon, Carl L Director Regular purchase transaction 981,023 $2.82 $2,766,484.86 1,368,339.00
01 May 2023 Gordon, Carl L Director Regular purchase transaction 716,157 $2.62 $1,876,331.34 4,204,852.00

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.